Kornitzer Capital Management Inc. KS Reduces Stock Holdings in The Clorox Company (NYSE:CLX)

Kornitzer Capital Management Inc. KS lessened its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 2.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 212,967 shares of the company’s stock after selling 4,554 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Clorox were worth $34,588,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CLX. Catalyst Capital Advisors LLC purchased a new stake in Clorox during the 3rd quarter valued at $54,000. Los Angeles Capital Management LLC lifted its position in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after purchasing an additional 10,149 shares during the period. Advisors Asset Management Inc. lifted its holdings in shares of Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after buying an additional 9,037 shares during the period. Natixis Advisors LLC lifted its holdings in Clorox by 8.3% in the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after acquiring an additional 4,839 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after buying an additional 13,038 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on CLX shares. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $158.21.

View Our Latest Report on CLX

Clorox Trading Down 1.9 %

Clorox stock opened at $147.91 on Tuesday. The stock has a 50-day moving average price of $159.17 and a 200 day moving average price of $159.61. The company has a market capitalization of $18.31 billion, a price-to-earnings ratio of 40.41, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the company posted $2.16 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.